David G. Mitchell, PharmD, MBA, CSP, FCPhA, of UC Davis Health, explains how AI-assisted prior authorizations have reduced denials and staff time without replacing pharmacist judgment.
|Articles|April 5, 2011
ACC 2011 Interivew on Atrial Fibrillation Cost in Rate vs Rythm Control
Dr. Poulin discusses his poster which is a cost analysis of 300 patients from Quebec, Canada, in an atrial fibrillation and congestive heart failure trial.
Advertisement
Advertisement
Related to this article
Advertisement
Advertisement
Trending on AJMC
1
Merck, Moderna Cancer Vaccine Cuts Melanoma Recurrence Risk by 42%
2
IDWeek Studies Tie RSV, Flu, and COVID-19 to Harm After Acute Illness
3
Former USAID Health Chief Says Aid Cuts Are Costing Children's Lives
4
It’s the Best of Times and Worst of Times for Cancer Care in Tampa
5